MetaCap

Becton Dickinson Insider Trades

NYSE: BDXHealth CareMedical/Dental InstrumentsUSD

182.75+2.59 (+1.44%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
14 · $2.23M
Shares bought / sold
0 / 13.20K
Net activity
Net selling $2.2 million

Becton Dickinson insider activity

Over the last 12 months, Becton Dickinson insiders reported 37 transactions on SEC Form 4: 0 open-market purchases and 14 sales. Insiders bought $0 and sold $2.2 million worth of stock, for net insider selling of $2.2 million. The largest seller was Polen Thomas E Jr, with $1.2 million in reported sales.

The most recent filing shows Feld Michael (EVP, Chief Revenue Officer) selling 76 shares at $183.70 on Sep 28, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BDX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

BDX insider transactions

Becton Dickinson insider transactions
DateInsiderTypeSharesValueFiling
Sep 28, 2026Feld MichaelEVP, Chief Revenue OfficerSale76$13.96KForm 4
Sep 2, 2026Roque VitorEVP & Chief Financial OfficerTax withholding190—Form 4
Aug 26, 2026Feld MichaelEVP, Chief Revenue OfficerSale165$31.10KForm 4
Aug 20, 2026Feld MichaelEVP, Chief Revenue OfficerTax withholding1,049—Form 4
Aug 13, 2026Polen Thomas E JrChairman, CEO and PresidentSale4,152$768.12KForm 4
Aug 13, 2026Polen Thomas E JrChairman, CEO and PresidentDisposition39,126$7.24MForm 4
Aug 13, 2026Polen Thomas E JrChairman, CEO and PresidentOption exercise43,278$7.24MForm 4
Aug 11, 2026Goette RolandEVP and President, EMEASale2,438$440.89KForm 4
Jul 27, 2026Feld MichaelEVP, Chief Revenue OfficerSale75$11.78KForm 4
Jul 2, 2026Muhsin BilalEVP & President Connected CareTax withholding1,935—Form 4
Jul 1, 2026Muhsin BilalEVP & President Connected CareAward14,342—Form 4
Jun 26, 2026Feld MichaelEVP, Chief Revenue OfficerSale75$11.46KForm 4
Jun 24, 2026Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmSale1,100$160.23KForm 4
Jun 10, 2026Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmSale1,100$166.63KForm 4
Jun 1, 2026Menziuso PeterEVP and President, BDIAward14,258—Form 4
Jun 1, 2026Polen Thomas E JrChairman, CEO and PresidentSale2,764$404.51KForm 4
Jun 1, 2026Polen Thomas E JrChairman, CEO and PresidentDisposition17,445$2.55MForm 4
Jun 1, 2026Polen Thomas E JrChairman, CEO and PresidentOption exercise20,209$2.55MForm 4
May 26, 2026Feld MichaelEVP, Chief Revenue OfficerSale75$11.05KForm 4
May 7, 2026Roque VitorEVP & Chief Financial OfficerAward1,721—Form 4
Apr 27, 2026Feld MichaelEVP, Chief Revenue OfficerSale74$11.24KForm 4
Apr 6, 2026Neal Shana CarolEVP and Chief People OfficerTax withholding1,146—Form 4
Mar 26, 2026Feld MichaelEVP, Chief Revenue OfficerSale75$11.76KForm 4
Mar 16, 2026Minnix LaneshaEVP and General CounselAward7,492—Form 4
Mar 2, 2026Spikner Pamela L.SVP Controller & CAOAward931—Form 4
Mar 2, 2026Roque VitorInterim CFOAward931—Form 4
Feb 26, 2026Feld MichaelEVP, Chief Revenue OfficerSale75$13.64KForm 4
Feb 18, 2026SCOTT BERTRAM LDirectorSale953$174.03KForm 4
Jan 27, 2026SCOTT BERTRAM LDirectorAward1,098—Form 4
Jan 27, 2026Jones Christopher Ian MontagueDirectorAward1,098—Form 4
Jan 27, 2026Huffines Robert LutherDirectorAward1,098—Form 4
Jan 27, 2026HAYES GREGORYDirectorAward1,098—Form 4
Jan 27, 2026RING TIMOTHY MDirectorAward1,098—Form 4
Jan 27, 2026Byington Carrie LDirectorAward1,098—Form 4
Jan 27, 2026ECKERT R ANDREWDirectorAward1,098—Form 4
Jan 27, 2026Brown William MDirectorAward1,098—Form 4
Jan 27, 2026Henderson Jeffrey WilliamDirectorAward1,098—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related